Aptevo Therapeutics Inc. (APVO) › Net IncomeAptevo Therapeutics Inc. (APVO) — Net IncomeAnnual figures by fiscal year, from SEC filings.2015: -$59.32M2016: -$112.42M2017: $6.97M2018: -$53.69M2019: -$40.45M2020: -$17.75M2021: -$28.46M2022: $8.03M2023: -$17.41M2024: -$24.13M2025: -$25.97M-$25.97M2015Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$25.97M-7.6%2024-$24.13M-38.6%2023-$17.41M-316.9%2022$8.03M+128.2%2021-$28.46M-60.3%2020-$17.75M+56.1%2019-$40.45M+24.7%2018-$53.69M-870.0%2017$6.97M+106.2%2016-$112.42M-89.5%2015-$59.32M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share